U.S. Primary Care Physicians Market Report 2024-2028: Trends and Challenges Shaping the Market, with Insights by Age Group, Type of Physician and Service
October 31, 2024 07:48 ET
|
Research and Markets
Dublin, Oct. 31, 2024 (GLOBE NEWSWIRE) -- The "Primary Care Physicians Market in US 2024-2028" report has been added to ResearchAndMarkets.com's offering.The primary care physicians market in US is...
Health, Wellness and Nutrition Market Trend Opportunity Profiles 2024 - Transformations in Customer Experience and Shopping Platforms Enable Growth and Innovation Until 2030
October 17, 2024 11:49 ET
|
Research and Markets
Dublin, Oct. 17, 2024 (GLOBE NEWSWIRE) -- The "Trend Opportunity Profile Series Health, Wellness, and Nutrition (4th Edition)" report has been added to ResearchAndMarkets.com's offering.This report...
Sutter Health Researchers Help Secure Nearly $70 Million NIH Grant to Advance Landmark Study on Healthy Aging
October 08, 2024 10:00 ET
|
Sutter Health
SAN FRANCISCO, Oct. 08, 2024 (GLOBE NEWSWIRE) -- (Oct. 8, 2024) – Sutter Health announced today researchers at its Sequoia Center for the Science of Aging will receive $21 million from a $67.7...
The Columbus Organization Appoints Regional Vice President
October 01, 2024 10:41 ET
|
The Columbus Organization
The Columbus Organization appoints Melissa Koontz as Regional VP of Care Coordination to align with ongoing nationwide growth.
Io Therapeutics, Inc., presented data from studies of IRX4204, the company’s phase II clinical stage RXR agonist for treatment of normal aging-related neurodegeneration, at the FASEB Science Research Conference on Cellular and Molecular Mechanisms of Brain Aging
September 18, 2024 11:07 ET
|
Io Therapeutics, Inc.
Io Therapeutics, Inc., presented on IRX4204 for treatment of brain aging, at the FASEB Conference on Cellular and Molecular Mechanisms of Brain Aging
Healthcare Fabrics Strategic Business Report 2023-2030: With Rising Incidence of Chronic Diseases and Wounds Fueling Need for Wound Management, Healthcare Fabrics Market Poised for Growth
August 26, 2024 09:41 ET
|
Research and Markets
Dublin, Aug. 26, 2024 (GLOBE NEWSWIRE) -- The "Healthcare Fabrics - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Healthcare...
Sensi’s Care Intelligence Research Finds Surprising Revelations Around Crucial Gaps In Senior Care at Nights and Weekends
August 12, 2024 10:11 ET
|
Sensi.AI
Sensi.AI's Care Intelligence Research Finds Surprising Revelations Around Crucial Gaps In Senior Care at Nights and Weekends
HouseWorks Continues Growth Strategy with New Partnership in Pennsylvania
August 08, 2024 09:00 ET
|
HouseWorks
BOSTON , Aug. 08, 2024 (GLOBE NEWSWIRE) -- HouseWorks Holdings, LLC (the “Company”), a leading personal care services platform serving the Northeast, announces that it has acquired Bridge City Home...
U.S. Post-Acute Market Report 2024: Post-Acute Executives Prioritize Artificial Intelligence For Workforce Management, Labor Shortages And New Federal Staffing Mandate Strain Nursing Homes
July 16, 2024 11:27 ET
|
Research and Markets
Dublin, July 16, 2024 (GLOBE NEWSWIRE) -- The "The 2024 U.S. Post-Acute Market Report" report has been added to ResearchAndMarkets.com's offering. The U.S. post-acute market is expected to reach...
Io Therapeutics, Inc., presented data from studies of IRX4204, the company’s phase II clinical development stage, highly selective third generation RXR nuclear receptor agonist compound, supporting its potential use for prevention and treatment of normal aging-related neurodegeneration, Parkinson’s disease, and Alzheimer’s disease
July 09, 2024 20:00 ET
|
Io Therapeutics, Inc.
Io Therapeutics presented data on the potential of IRX4204 for treatment of aging-related neurodegeneration, Parkinson's disease, and Alzheimer's disease